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ORIGINAL ARTICLE
Retrospective Study

Obtaining research biopsies during pediatric colonoscopy:
Safety and adverse events
Jennifer Mait-Kaufman, Stacie Kahn, Gitit Tomer

Abstract

Jennifer Mait-Kaufman, Gitit Tomer, Department of Pediatric
Gastroenterology and Nutrition, Albert Einstein College of
Medicine, Children’s Hospital at Montefiore, Bronx, NY 10467,
United States
Stacie Kahn, Albert Einstein College of Medicine, Bronx, NY
10467, United States

AIM: To investigate the safety profile of acquiring
additional intestinal biopsies for research purposes in
children undergoing a medically indicated colonoscopy.
METHODS: A retrospective review of 122 pediatric
patients who underwent colonoscopy over a 9 mo time
period was completed. 38/122 participants consented
to a research study in which 4 additional biopsies were
obtained, in addition to routine biopsies. The outcomes
after colonoscopy were measured in the research
participants, and compared to 84 control participants who
did not consent for the study. Groups were compared
with regard to number of biopsies obtained, underlying
diagnosis, and both serious and minor adverse outcomes.
Data was collected including: age, gender, race, indication,
diagnosis, number of biopsies obtained per case and
post procedure adverse events. Medical records were
reviewed and a questionnaire was completed by each of
the ten gastroenterologists who performed procedures
during the study. Physicians were asked about individual
patient outcomes to ensure that all adverse events, such
as perforation, excessive bleeding, infection, and minor
gastrointestinal outcomes, were captured and included.
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RESULTS: The research group had more biopsies
obtained (mean = 13.58 ± 4.21) compared to controls
(mean = 9.33 ± 4.40), P ≤ 0.0001, however there
was no difference in adverse events. Serious outcomes,
defined as perforation, bleeding and infection, did not
occur, in either group. As such, the relationship between
serious adverse events and number of biopsies obtained
was not determined. Minor gastrointestinal outcomes,
such as abdominal pain, diarrhea or vomiting, were
reported in 21 patients (8 research participants and 13
control participants) however the incidence of minor
gastrointestinal outcomes between the two groups did
not vary significantly, P = 0.45. Additionally, the mean
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number of biopsies obtained in patients who had a
minor outcome (mean = 12.1 ± 0.77), compared to
those with no adverse outcome (mean = 10.34 ± 0.5),
revealed no statistical difference between the groups
(P = 0.12), suggesting that number of biopsies is not
associated with incidence of minor adverse events.

related to gastrointestinal bleeding, bleeding was
[3]
not defined . Other pediatric studies did not include
[6]
bleeding in their outcome analysis . Infection, similarly
regarded as a serious and uncommon outcome after
[11]
colonoscopy, has not been widely studied in pediatrics .
Likewise, minor post-procedure gastrointestinal symp
toms, such as bloating and abdominal pain, are not well
[12]
described in the pediatric literature .
The current pediatric studies are limited in number
and do not quantify the number of routine biopsies
obtained per procedure which may be a risk factor for
adverse events. Additionally, these studies have not
addressed whether obtaining additional biopsies solely
for research purposes imposes additional risk to the
patient. To our knowledge, this issue has not been
addressed in the pediatric or adult literature. It is critical
to establish the safety profile of collecting additional
biopsies for research during routine procedures, so that
investigators seeking institutional review board (IRB)
approval are able to proceed with important research
questions. The absence of this risk assessment may
explain why studies involving the collection of pediatric
biological specimens are difficult to pursue. Such IRB
protocols pose a challenge to both author and reviewer,
in that the lack of prior safety data serves as an obstacle
for IRB approval. To address this gap, we performed a
retrospective review for all children undergoing routine
medically indicated colonoscopies and measured
adverse events. Thirty-one percent of the participants
had previously consented for a research study involving
the acquisition of four additional intestinal biopsies
designated for research purposes. By comparing adverse
events in the research study participants to patients
who did not consent, the controls, we established that
acquiring additional biopsies for research alone is safe.

CONCLUSION: Patients participating in research requir
ing acquisition of additional biopsies for research purposes
alone, are not at an increased risk of adverse outcomes.
Key words: Pediatric colonoscopy; Outcomes; Research;
Safety; Intestinal biopsy
© The Author(s) 2015. Published by Baishideng Publishing
Group Inc. All rights reserved.

Core tip: Acquiring biopsies for research purposes during
a colonoscopy may facilitate translational research in the
field of gastroenterology. However, the safety profile of
acquiring research biopsies has not been established.
Our study is the first to conclude that acquiring additional
biopsies for research during a colonoscopy does not pose
additional risk to the pediatric patient. This manuscript
may serve as a reference to researchers applying for IRB
approval in biological specimen studies. Additionally, our
study is additive to the body of literature on outcomes
after pediatric colonoscopy, in that minor gastrointestinal
symptoms were the only reported adverse event after
colonoscopy.
Mait-Kaufman J, Kahn S, Tomer G. Obtaining research biopsies
during pediatric colonoscopy: Safety and adverse events. World J
Gastrointest Endosc 2015; 7(7): 736-740 Available from: URL:
http://www.wjgnet.com/1948-5190/full/v7/i7/736.htm DOI:
http://dx.doi.org/10.4253/wjge.v7.i7.736

MATERIALS AND METHODS
We performed a retrospective review of all pediatric
patients undergoing a medically indicated routine
colonoscopy from June 5, 2013-March 5, 2014. Anesth
esia was provided by pediatric anesthesiologists.
Patients who had previously provided written and
oral consent for a biological specimens study were
identified (n = 38); these participants consented to have
four additional intestinal biopsies taken for research
purposes alone. This research-consented cohort was
then compared to non-study participants (n = 84), who
had only routine biopsies obtained during the procedure.
Data was collected including: age, gender, race,
indication, diagnosis, number of biopsies obtained per
case and post procedure adverse events. Post-proce
dure adverse events were defined as events occurring
within one week of the procedure. Medical records were
reviewed for patient phone calls, general practitioner
and gastroenterology clinic appointments, emergency
department visits and hospital admissions within one
week post-procedure. For those patients who were
admitted to the hospital prior to their colonoscopy, the

INTRODUCTION
Colonoscopy with biopsies is a common procedure
in children for the evaluation and diagnosis of gas
trointestinal disease. Serious complications, such
as perforation and bleeding are routinely discussed
during the consent process, however, these events
[1-3]
are rare
. Several adult studies have sought to
measure the incidence of adverse outcomes during
[2,4,5]
routine procedures
, and this data has largely
[6]
been applied to the pediatric population . In adults,
colorectal perforation is presumed to occur in 0.09%
[7,8]
of the general population , while it remains unclear
as to whether patients with pre-existing inflammatory
bowel disease (IBD) are at an increased risk for serious
[7,9,10]
outcomes, such as perforation
. The incidence of
bleeding after colonoscopy is thought to occur infre
[8]
quently during routine procedures .
There is limited data on serious adverse events in
children, such as bleeding. Although one study found
that 38.6% (34/86) of all reported complications were
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Table 1 Participant demographics
Research group
(n = 38)
Sex
Male, n (%)
Female, n (%)
Age in years, n (%)
0-5
6-12
13-21
Race
White, n (%)
Non-white, n (%)
Diagnosis
IBD2, n (%)
Normal
histology, n (%)
IBD diagnosis
CD3, n (%)
UC4, n (%)
5

IC , n (%)
History of IBD
Yes
No

Table 2 Minor gastrointestinal outcomes
Control group P value
(n = 84)

20 (52.6)
18 (47.4)

48 (57.1)
36 (42.9)

0.64

1 (2.6)
10 (26.3)
27 (71.1)

16 (19.0)
19 (22.6)
49 (58.3)

0.05

5 (13.2)
33 (86.8)

26 (31)
58 (69)

0.04

17 (44.7)
21 (55.3)

21 (25)
63 (75)

0.03

11 (28.9)

10 (11.9)

5 (13.2)

11 (13)

1 (2.6)

0

8
9

12
9

1

Research group Control group
(n = 38)
(n = 84)
Gastrointestinal symptom after
Procedure, n (%)
Yes
8 (21.1)
No
30 (78.9)
Mechanism of reporting
Phone call
6
PGI2 clinic visit
0
ED visit
2
Inpatient
0
Management
Outpatient
5
Admission to
1
hospital
Referral to ED
2
Continued admission
0
Gastrointestinal symptom3 (%)
Abdominal pain only
2 (5.3)
Abdominal pain
3 (7.9)
+ diarrhea and/or
vomiting
Rectal bleeding
3 (7.9)
Other
2 (5.3)
Number of Biopsies
Mean ± SD4
13.6 ± 4.2

0.23

0.54

1

All P values calculated to significance level of 0.05, 2Inflammatory Bowel
Disease, 3Crohn’s disease, 4Ulcerative colitis, 5Indeterminate colitis.

13 (15.5)
71 (84.5)

P value1

0.45

6
1
1
5

0.14

6
1

0.81

1
5
4 (4.8)
5 (6.0)

0.82

2 (2.4)
3 (3.6)
9.3 ± 4.4

< 0.0001

1

All P values calculated to a significance level of 0.05, 2pediatric gastroenterology, 3In research group, 1 patient with both abdominal pain and
rectal bleeding, 1 with both rectal bleeding and constipation and in control
group, 1 patient with rectal bleeding and diarrhea; 4standard deviation.

inpatient record was reviewed.
We administered a questionnaire to the ten gastroen
terologists who performed procedures during the afore
mentioned time period regarding individual patient
outcomes to ensure that all adverse events, such as
perforation, excessive bleeding, infection, and minor
gastrointestinal outcomes, were captured and included.
This study was approved by the Office of the Human
Research Protection Program, Institutional Review
Board at Albert Einstein College of Medicine, Bronx, NY.

age were observed in the research compared to the
control groups, P = 0.04 and P = 0.05, respectively. One
patient (2.6%), age 0-5, participated in the research
study, compared to 16 (19%) who underwent routine
colonoscopy alone (P = 0.05). No statistical difference
in gender distribution was observed when comparing
research to control participants.
The research cohort consisted of 38 patients, 17/38
(44.7%) of whom had IBD, compared to 21/84 (25%)
of the patients in the control group (P = 0.03) (Table
1). IBD diagnosis type, such as Crohn’s disease (CD) or
ulcerative colitis (UC), did not vary significantly between
the two groups, P = 0.23.
There were no cases of perforation, infection or
hemorrhage in the research or the control group. Given
that no serious outcomes occurred in our cohort, the
relationship between number of biopsies and serious
adverse events was not measured. Minor gastroin
testinal outcomes, however, did occur in 8/38 research
participants, and 13/84 control participants (Table 2).
The incidence of minor gastrointestinal outcomes was
not statistically different when comparing the research
and control groups, P = 0.45, although the research
group had significantly more biopsies obtained per
procedure, P < 0.0001. Additionally, the mean number
of biopsies obtained in patients who had a minor
outcome (mean = 12.1 ± 0.77), compared to those
with no adverse outcome (mean = 10.34 ± 0.5),
revealed no statistical difference between the groups

Statistical analysis

Differences in participant demographics between groups
were compared using analysis of variance or t tests for
2
continuous variables and χ or Fisher’s exact tests for
categorical variables. All analyses were performed using
GraphPad Prism version 6 (San Diego, CA). All tests for
significance were two-sided, and a value of P < 0.05
was considered significant.

RESULTS
A total of 122 colonoscopies were performed during the
study period: 38 patients consented to have additional
biopsies obtained for research during the medically
indicated procedure, compared to 84 non-research
related cases. One thousand two hundred and ninety
biopsies were obtained, including 136 intestinal biopsies
for research alone. The average number of biopsies
obtained per case was significantly higher in the research
cohort, 13.6 compared to 9.3 in the control group, (P <
0.0001) (Table 1). Participant demographics are detailed
in Table 1. Of note, statistical differences in race and
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[10]

which refutes prior findings . A larger percentage of
IBD patients (8/38, 21%) sustained minor adverse
outcomes compared to non-IBD patients (13/84,
15.5%), however this difference was not found to be
statistically significant. Our findings support a prior
[9]
study by Tam et al that evaluated pain indices in
children with IBD, pre and post procedure, and found
that patients with functional bowel disease report more
[9]
pain, compared to children with IBD .
Interestingly, our research-consented cohort con
sisted of a larger percentage of IBD patients, 44.7%
compared to 23.8% in the control group. From this,
we may conclude that parental concern is greater in
children more likely to have IBD, which may explain a
greater willingness to participate in studies or to benefit
from research. Alternatively, selection bias may impact
the recruitment of children most likely to have IBD. In
this study, however, all children undergoing colonoscopy
during the aforementioned time period were asked to
participate.
Given that serious adverse events did not occur
in our cohort, we were unable to correlate number of
biopsies obtained with incidence of serious adverse
events. However, we did observe that of the patients
who reported minor gastrointestinal outcomes, most
(71.4%) reported the same symptom with which they
presented for colonoscopy. Therefore, minor gastroin
testinal events occurring after a procedure may be
secondary to the primary gastrointestinal complaint,
rather than the procedure. In regard to the consent
process and clinical practice, clinicians may reassure
parents that minor symptoms after a procedure are
most commonly related to underlying symptoms on
presentation, and not to the colonoscopy itself.
There are few studies in the current pediatric
literature that discuss minor adverse outcomes after
colonoscopy. Our study found that 17.2% of our popu
lation reported minor symptoms after colonoscopy,
which is consistent with prior data, for example,
[12]
Steiner et al
found that post-procedure symptoms
occur in 14%-17% of patients; sore throat, diarrhea
and excessive gas occurred in 6% of patients, while
[12]
abdominal pain occurred in 3% . In our study 1.6%
of participants were admitted post procedure for
observation, while Steiner et al. admitted 1.1% patients,
suggesting that the general concern level regarding
minor symptoms is low. Of the 17 patients who reported
symptoms, 1 was under the age of 5, suggesting
either that minor symptoms are more common in older
children, or that underreporting is at play in younger age
groups. On a similar note, only 1 patient between the
ages 0-5 participated in the research study, compared
to 16 children in the control group under the age of 5,
suggesting that parents of very young children are less
likely to consent for studies requiring the collection of
biological specimens. In one study, children 0-5 years of
age were the most likely group to have a complication,
[3]
P ≤ 0.001 ; this supports the notion that very young

Table 3 Indications for colonoscopy
Indication (%)
Abdominal pain
Diarrhea
Rectal bleeding
Weight loss
Loss of appetite
Constipation
Vomiting
Fatigue
Fever
Joint pain
Rash

Research (n = 38) Control (n = 84) P value
50
44.7
36.8
44.7
34.2
18.4
15.8
23.7
7.89
10.5
5.26

50
36.9
34.5
20.2
10.7
15.5
14.3
3.57
3.57
1.19
0

1

1
0.41
0.8
0.01
0.002
0.68
0.83
0.001
0.31
0.02
0.03

1

All P values calculated to a significance level of 0.05.

(P = 0.12), suggesting that number of biopsies is not
associated with incidence of minor adverse events.
When comparing mechanism of reporting and mana
gement of adverse minor events no statistical differences
were noted when comparing research participants to
controls. Likewise, gastrointestinal symptoms reported
as minor events were similar between the two groups.
Overall, during this time period, 38 children with
IBD underwent colonoscopy: 47.4% (18/38) of this
group were newly diagnosed patients, 11 with CD, 6
with UC, and 1 with indeterminate colitis, while 52.6%
(20/38) had been previously diagnosed with IBD. Minor
outcomes occurred in 21% (8/38) of patients with IBD.
The incidence of minor adverse events in IBD versus
non-IBD patients, did not vary significantly between the
two groups, P = 0.45.
The most common indication for colonoscopy was
abdominal pain, occurring in 50% of patients, while
diarrhea was the second most common indication (Table
3). Weight loss, loss of appetite, fatigue, joint pain and
rash occurred more often in the research group, P =
0.01, P = 0.002, P = 0.001, P = 0.02, and P = 0.03,
respectively.

DISCUSSION
To our knowledge, no studies to date have evaluated
the safety profile of taking additional intestinal biopsies
for research purposes. Obtaining intestinal biopsies for
research may facilitate investigations that will further
our understanding of pediatric gastrointestinal illnesses.
Our study shows that participation in research during
a medically indicated colonoscopy does not place the
patient at an increased risk for bleeding, perforation,
infection, or minor gastrointestinal outcomes, which
is in line with prior pediatric studies, as complications
[3,6,7,9,11,13]
during routine colonoscopy are rare
, and can
be applied to studies involving biological specimens.
Adverse events after pediatric colonoscopy, particu
larly in regard to IBD, have not been well studied, as
subjects with pre-existing disease are often excluded
[6]
from the cohort . Our data suggests that patients with
IBD are not at increased risk for perforation or bleeding,
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The publication of this study may serve as a reference for researchers seeking
IRB approval in biological specimen studies, and suggests the need for larger
studies in the future.

patients may have an increased risk for complications
after colonoscopy and that children over the age of 5
may be more suitable candidates for research studies
involving acquisition of additional biopsies.
The limitations of our retrospective study include
small sample size, limited duration of the study, and
selection bias, as underlying gastrointestinal symptoms
may have affected study outcome. Additional studies
with larger groups of pediatric patients undergoing
colonoscopy for medical reasons, while participating in
research, are warranted in order to further attest that
no additional risk is imposed to the patient. This will
allow researchers to pursue questions that will enhance
our current knowledge of chronic gastrointestinal pro
blems in children, specifically IBD.
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